National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Mike Hilton, Ph.D. Reissuance of PA-18-390, PA-18-391, and PA-18-413 Purpose The purpose of this announcement is to replace a series of recently expired Program Announcements in order to communicate the broad scope of research topics of interest to the Division of Epidemiology and Prevention Research at the National Institute on Alcohol Abuse and Alcoholism. Advancing knowledge about the epidemiology of...
President Nixon signed the Comprehensive Alcohol Abuse and Alcoholism Prevention, Treatment, and Rehabilitation Act of 1970 on December 31, 1970. This legislation was also known as the Hughes Act for Senator Harold Hughes, a person who was in recovery from alcohol use disorder (AUD) and championed the cause of AUD research. The Hughes Act authorized a comprehensive Federal program to...
NIAAA’s major initiatives seek to address alcohol-related issues across the lifespan. Our aim is to reduce the tremendous burden of illness resulting from the misuse of alcohol by: Preventing children and adolescents from beginning and continuing to drink alcohol Offering effective intervention for problem alcohol use at all ages To accomplish this, we support research in areas ranging from basic...
Research on Promising Medications (not approved by the U.S. Food and Drug Administration [FDA]) to Treat Alcohol Use Disorder (AUD) Varenicline (Chantix®) , a medication approved for smoking cessation, was found in a recent 200-patient clinical trial conducted by NIAAA’s Clinical Investigations Group (NCIG) to reduce alcohol consumption and craving among people who are alcohol-dependent. Varenicline may work by partially...